HF 4014 Summary

• Allows opioid treatment program clients to receive individualized take-home doses for one weekend day and state/federal holidays, regardless of treatment length, replacing the previous single-dose restriction.

• Removes specific methadone-only restrictions that previously limited unsupervised doses to one per week during first 90 days, two per week during second 90 days, and three per week during third 90 days of treatment.

• Repeals subdivisions 4 and 7 of Minnesota Statutes 245G.22, eliminating requirements for face-to-face meetings when doses exceed 150 milligrams of methadone or 24 milligrams of buprenorphine daily.

• Requires practitioners to review federal Code of Federal Regulations criteria when determining eligibility for take-home doses beyond those allowed for clinic closures, including absence of recent drug abuse, program attendance, and safe storage assurance.

• Maintains diversion control measures requiring programs to contact at least 5 percent of clients with unsupervised use monthly to verify medication containers are returned and document any diversion issues.